New diabetes drug enters Head-to-Head test against standard insulin
NCT ID NCT07018453
Summary
This study is testing whether a new drug called SHR-3167 works as well as or better than a standard long-acting insulin (degludec) for controlling blood sugar in people with type 2 diabetes. It involves 173 adults who are already using insulin with or without other diabetes pills. Researchers will measure changes in blood sugar levels over time to see which treatment is more effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400000, China
-
Zhongshan Hospital Affiliated to Fudan University
Shanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.